© Springer Nature Singapore Pte Ltd. 2019
M. S. Akhtar, M. K. Swamy (eds.)Natural Bio-active Compoundshttps://doi.org/10.1007/978-981-13-7438-8_7

7. Biotechnological Exercises in the Production of Secondary Metabolites and Its Significance in Healthcare Practices

Mohammed Shariq Iqbal1 and Mohammad Israil Ansari2  
(1)
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow, Uttar Pradesh, India
(2)
Department of Botany, University of Lucknow, Lucknow, Uttar Pradesh, India
 
 
Mohammad Israil Ansari
7.1 Introduction
7.2 Recent Advancements in Secondary Metabolite Production
7.3 Current Biotechnological Exercises Employed in the Production of Secondary Metabolites from Higher Plants
7.3.1 Therapeutically Significant Secondary Metabolite Production by Plant Tissue Cultures Technique
7.3.2 Secondary Metabolite Production by Organ Cultures Technique
7.3.3 Secondary Metabolite Improvement by Addition of Precursors
7.3.4 In Vitro Elicitation Technique
7.3.5 Enhancement of Secondary Metabolites by Cultures of Hairy Root
7.3.6 Production of Secondary Metabolite by Genetic Transformation in Hairy Root Culture
7.3.7 In Vitro Secondary Metabolite Production by Endophytes
7.3.8 Secondary Metabolites Scaling-Up by the Use of Bioreactors
7.3.9 Secondary Metabolite Immobilization and Accumulation
7.3.10 Secondary Metabolite Production by Metabolic Engineering
7.4 Secondary Metabolites of Pharmacological Significance
7.5 Secondary Metabolites Significant in Healthcare
7.6 Conclusions and Future Prospects
References

Abstract

Plants produces various secondary metabolites that are economically vital. They deliver products for medications in the form of naturally attained stuffs, like fragrances and flavor, pigments and dye, foodstuff or additives, pesticides, and therapeutics. The increasing industrial prominence of secondary metabolites in recent years has resulted in an exceedingly prodigious curiosity in the production of secondary metabolites to meet required demands. Biotechnological exercises in the production of secondary metabolites have a great importance. For certain phytochemicals, bioreactors can be used for the large-scale production. In the case of culture production of secondary metabolites, the right media selection could increase yeild up to 20–30 times, but for several other bio-active compounds, which are in very small amounts, cell culture techniques are not feasible. Elicitation by phytoalexins has led to raised production of secondary metabolites. The approach of root/shoot hairy cultures is another technique, but is hindered at scaling-up stages. On the other hand, metabolic engineering is a technique, which could aid in the enhancement of certain secondary metabolites. This methodology can fabricate secondary metabolites in cell cultures or in the plants itself. Thus, metabolic engineering gives the impression of provocative approach to enhance the metabolites produced by the cell. Therefore, current technologies will benefit to encompass and improve the sustained utility of the higher plants as rekindling sources of phytochemicals, particularly compounds related to therapeutic importance. The present chapter summarizes the different biotechnological exercises associated with the fabrication of secondary metabolites. Moreover, it also discusses the various biotechnological techniques for the production of specific and valued secondary metabolites used in the healthcare practices.

Keywords

Cell suspension cultureGene duplication technologyPhytochemicalsMicropropagationSecondary metabolites

7.1 Introduction

Plants have the capability to synthesize diverse secondary metabolites, which are made up of organic molecules with unique carbon arrangements. Secondary metabolites are not required for cells to survive, but it plays a vital character in an interface of the cells with its ambiances, confirming the constant existence of the organism to its biomes (Ncube and Staden 2015). Normally the secondary metabolites are of low molecular weight, and its production is specific to cell, tissue, and organ. These compounds frequently change among germplasm from a similar population of plants in reverence to their quantity and forms (Matsuura et al. 2018). Secondary metabolites look after plants against biotic and abiotic stresses, viz., microorganisms, nematodes, insects, and animals and temperature, moisture, shading, injury, and heavy metals, respectively. Due to the excessive commercial importance, they are extensively used as chemical such as for medications, flavors, essence, insect repellent, and dyes. Most of the significant therapeutic biomolecules are alkaloids which are biosynthesized mainly from amino acids. However plant secondary metabolites can be chemically categorized into different types, i.e., phenolics (Wuyts et al. 2006; Iqbal et al. 2017), terpenes (Singh and Sharma 2015), compounds containing nitrogen (Ejaz et al. 2017), and compounds containing sulfur (Kang and Kim 2007). Due to the occurrence of varied diversity and multifaceted performance of secondary metabolites, it is assumed to be of enormous significance. Secondary metabolites hold various therapeutic properties, and thus it is of immense importance to mankind for health benefits (Forbey et al. 2009).

Subsequently secondary metabolites are bio-active compounds which are substantial for the stability of the organisms. Several secondary metabolites meddle with pharmacological assets, which mark them attention-grabbing for various bio-pharma and agri-biotechnological utilizations (Rai et al. 2009). The outcome of secondary metabolites as by-products from organism in response to the external stimuli (biotic and abiotic) is another cause. Thus, the yield of bio-active products is a natural, biochemical, and bioenzymatic process that happens in all organisms during metabolism process (Dias et al. 2012). The system of metabolites, functional with enzymatic reaction throughout the course of metabolic process, is known as metabolome. According to Moghe and Last (2015), a metabolome comprises of all the manacles of responses, relating to enzymes and its substrates in the metabolic process and finishing up in the materialization of the metabolites (primary and secondary). In the process when pyruvate enters the mitochondria to undergo in tricarboxylic acid cycle, it gets converted into acetyl CoA. The acetyl CoA on further metabolism produces secondary metabolites required for the cell. On the other hand, the mitochondria undergoing tricarboxylic acid cycle synthesize macromolecules or primary metabolites required for the survival of the cell. The systematic synthesis of metabolite (primary and secondary) is shown in Fig. 7.1. Various secondary metabolites are produced during this process, essential for the development of organism. Thus, the usage of compounds like perfumes, caffeine, ephedrine, nicotine, essential oils, piperine, capsaicin, and strychnine and hallucinogen compounds like tetrahydrocannabinol, heroin, cocaine, morphine, and natural dyes is formed as secondary metabolite by various organisms. Therefore, for biotechnologists, it’s a huge task to elucidate techniques to outgrow these bio-active compounds in better quality and in abundant amount. The principal and customary mode to excerpt the phytochemicals is to cultivate the individual plant in glasshouses or in the field. In this circumstance, cell culture or tissue/organ culture is imperative methods of in vitro micropropagation to extract specific phytochemicals.
../images/470709_1_En_7_Chapter/470709_1_En_7_Fig1_HTML.png
Fig. 7.1

Metabolomic biosynthesis of primary and secondary metabolites

As an alternative methodology, biotechnologist could isolate and express the genes responsible for the formation of particular secondary metabolite of therapeutic significance in a particular biosynthetic pathway. If this technique will be successful, then recombinant DNA technology on bacteria or yeasts could flourish, which may produce valuable plant secondary metabolites for therapeutic use (Pandey et al. 2014). The biosynthesis of antibiotics by means of genes coding enzymes approach, at present, is of inordinate attainment. In recent years, microorganisms have been exploited, and techniques have been developed to express the genes responsible for alkaloid biosynthesis for its overproduction (Pickens et al. 2011). Eventually, it is conceivable to yield desired alkaloids from cells of yeast or bacteria recombinant DNA technology. Although if particular secondary metabolite of plant or microorganism causes prevention to the growth of pests or pathogens, thus genetic transformation of vulnerable plants may perhaps be added prospective for its utilization. For almost two decades, researchers in the field of biotechnology have attempted to yield beneficial secondary metabolite in cell or tissue/organ cultures. However cell cultures which are undifferentiated have generally botched to form such beneficial compounds judiciously, as distinguished tissue/organ cultures like root cultures linger on as lively as whole plant (Ochoa-Villarreal et al. 2016).

The basic benefit of present techniques is to make available of uninterrupted, consistent source of plant-originated phytochemicals and possibly will be amplified on large-scale production culture of cells or tissue/organ for its extraction. The technique holds prominent advantage for meticulous fabrication of numerous, useful secondary metabolites upon application. The present output and production of secondary metabolite cannot achieve the commercial goal of phytochemicals bioprocessed for the fabrication of most the secondary metabolites of therapeutic importance. In the direction to expand the boundaries, recent progressions and new prospects in plant organ or cell/tissue culture-based procedures are being critically studied and experimented. In such experimentations, novel approaches to develop the preferred secondary metabolites should be taken into consideration for better future. One of the foremost glitches that come across in this arena of research is the absence of elementary information of biosynthesis pathways and mode of action accountable for the fabrication of secondary metabolites. Moreover, it also discusses the various biotechnological techniques for the production of specific and valued secondary metabolites used in the healthcare practices.

7.2 Recent Advancements in Secondary Metabolite Production

Plant cell or tissue/organ cultures embrace prodigious potential for meticulous propagation of innumerable, beneficial secondary metabolites upon requirement and demand. Outcomes associated to cell cultures achieving the fabrication of specific therapeutic phytochemicals at a level parallel or better than that of whole plant have been enhanced in the last few decades (Vijaya et al. 2010; Ncube and Staden 2015). In the course to accomplish amplified yields, appropriate to utilize commercially, attempts have been made to find the biosynthetic actions of cell cultures, accomplished by proper rectification of conditions for growing of culture, choosing high-producing strains with precursor nourishment, biotransformation, and immobilization procedures (DiCosmo and Misawa 1995; Ncube and Staden 2015). Organ culture technique (transgenic root hair cultures) has transfigured the character of secondary metabolite in plant tissue culture. The method is inimitable in their biosynthetic and genetic permanency, quick in growth, and efficiently sustainable. By improvising the approach, an extensive variety of biochemical compounds has been manufactured (Giri and Narasu 2000). Recent progresses in cell or tissue/organ culture technique, associated with enrichment by genetic engineering, have developed biomolecules of pharmaceutical and nutraceutical significance and other additional valued constituents (Hansen and Wright 1999). Furthermore, improvements in the enzyme technology, molecular biology, microbiology, biochemistry, and fermentation technology enhanced the cell culture techniques that have developed a feasible source of secondary metabolites of therapeutic and agricultural importance (Abdin 2007; Barbulova et al. 2014).

Genome alteration technique resulted in comparatively producing huge amounts of expected biosynthetic compounds provided by plants on treatment with genome engineered viruses. The transgenic plants could produce biomolecules in limited quantity, without any additional interference with other biosynthetic pathways (Abdin and Kamaluddin 2006). However, for the large-scale production of secondary metabolites, tissue culture technique is established, which is an attractive methodology beside outmoded approaches for the production of secondary metabolites, as it deals with meticulous resource of phytochemicals that are not dependent on the availability of whole plants (Sajc et al. 2000). Some of the metabolites of nutraceutical and pharmaceutical significances are summarized in tabular form (Table 7.1).
Table 7.1

Bio-active compounds of nutraceutical and pharmaceutical significance

Class

Known metabolites numbers

Examples

References

Alkaloids

21,000

Quinine, cocaine, psilocin, reserpine, caffeine, nicotine, morphine, atropine, berberine, ephedrine, vincristine, galantamine, vincamine, quinidine

Wink (2010)and Kennedy and Wightman (2011)

Non-protein amino acids (NPAAs)

700

Azatyrosine, canavanine

Wink (2010)

Amines

100

Methylamine, dimethylamine, trimethylamine, aziridine, piperidine

Iqbal et al. (2014a, b)

Cyanogenic glycosides

60

Amygdalin, dhurrin, linamarin, lotaustralin, prunasin

Wink (2010)

Glucosinolates

100

Sinigrin, glucotropaeolin, gluconasturtiin, glucoraphanin

Wink (2010)

Alkamides

150

N-Isobutyl-2E-decenamide and N-isobutyl-decanamide

Molina-Torres et al. (2004)

Lectins, peptides and polypeptides

2000

Concanavalin A

Reeke et al. (1975)

Terpenes

>15,000

Azadirachtin, artemisinin, tetrahydrocannabinol

Tiwari and Rana (2015)

Steroids and saponins

NA

Cycloartenol

Babiychuk et al. (2008)

Phenylpropanoids, lignins, coumarins and lignans

2000

Resveratrol

Kennedy and Wightman (2011)

Polyacetylenes, fatty acids and waxes

1500

Oleic acids

Minto and Blacklock (2008)

Polyketides

750

Aflatoxin B1, geldanamycin, erythromycin

Crawford and Townsend (2010)

Carbohydrates and organic acids

200

Formic acid, lactic acid, citric acid

Nakui et al. (2009)

7.3 Current Biotechnological Exercises Employed in the Production of Secondary Metabolites from Higher Plants

Cell or tissue/organ cultures of plant can be done consistently within sterilized surroundings from portions of the plant parts like roots, stems, leaves, and meristems for proliferation and extraction of valuable secondary metabolites. Enrichment in secondary metabolite fabrication could be done by strain development approaches, as variety of cell lines, and media optimizations can be used (Jan et al. 2017). At present the sturdy and mounting requirement in marketplace for natural and non-convectional products has progressed. Considering the in vitro plant-originated compounds as promising industrial unit for secondary metabolite products has generated the path for innovative exploration for secondary phyto-product countenance (Karuppusamy 2009). There are many different benefits of fabricating valued secondary phyto-metabolites by cell/tissue culture, than by in vivo technique in the plant. It can be summarized as under:
  • Production of phytochemical can be more consistent, natural, and more foreseeable.

  • Extraction of the phytochemical can be quick and effective, when compared with isolation from complete plant.

  • Phytochemicals generated in vitro can directly be equivalent to the phytochemicals produced by complete plant.

  • Inquisitive phytochemicals can be evaded in cell cultures, which cannot be done in the plants grown infield.

  • Cell/tissue cultures can harvest definite and customary phytochemicals in bulk quantities.

  • Cell/tissue cultures are a prospective exemplary to investigate and testify elicitation.

  • Radiolabeling in cell/tissue cultures could be done, so that the stored secondary metabolites, when delivered as feedstuff to experimental models (animals), can be outlined during metabolic process.

Various research on enhancement of secondary metabolites production, has increased now a days for producing an extensive variety of valued secondary phytochemicals in callus or suspension cultures, however further research is required to establish technique for organ cultures of well-known plant as well (Davioud et al. 1989). This condition repeatedly arises when the phytochemical of importance is only formed in specific plant tissues/organ of the parental plant. A crucial case in point is in Panax ginseng. As in this plant, in vitro saponin and additional valuable metabolites are particularly formed in its organ (root) culture. Likewise, medicinal plant Hypericum perforatum, which holds the hyperforins and hypericins (in foliar glands), has not established the capability to accrue phytochemicals in undistinguished cells (Smetanska 2008). Therefore approaches need to be developed for fabrication of secondary metabolites on large scale. The rigorous accomplishments have been focused on generating natural remedies or chemo-protecting compounds (secondary metabolites) obtained from plant cell or tissue/organ culture by the following subsequent approaches.

7.3.1 Therapeutically Significant Secondary Metabolite Production by Plant Tissue Cultures Technique

With the advancements in the field of research and development, the technique like tissue culture for fabrication of phytochemicals has embellished beyond its potentials (Vijaya et al. 2010). The chief edges of a cell culture methodology over the standard cultivation process of complete plants may be illustrious as under:
  • Production of valuable phytochemicals under controlled environment without the impact of conditions of soil or fluctuations in climatic.

  • Microorganisms and pests free cells cultures.

  • Reproduction of cells from any plant could simply enrich particular metabolites.

  • Reduction of labor expenses and increased production, as automated regulation of cell growth and balanced parameter of metabolite progressions, could be done.

  • Callus cultures could be the source of organic constituents which can be easily extractable.

Some of the secondary metabolite productions in culture medium are cathinone alkaloids by suspension culture (Anderson et al. 1987), allicin by callus culture (Malpathak and David 1986), caffeine by callus culture (Waller et al. 1983), anthraquinones by suspension culture (Dornenburg and Knorr 1999), ginkgolide A by suspension culture (Carrier et al. 1991), L-DOPA by suspension culture (Wichers et al. 1993), etc.

7.3.2 Secondary Metabolite Production by Organ Cultures Technique

Organ culture is a technique where rapid propagation can be done by cutting small sections of the plant organ. Small slicing of Fritillaria unibracteata can swiftly propagate the bulb by organ culture process. The sliced bulbs were grown in MS media, supplemented with 4.44 mole indole-3-butyric acid (IBA) and 5.71 mole indole-3-acetic acid (IAA). The cultivated bulbs were collected after 50 days of culture period. The growth rate was enhanced by 30–50 times, which was higher than that of normal conditions. The magnitude of secondary metabolites was elicited like alkaloids and other valuable phytochemicals in the cultured bulbs than in the normal growing bulb (Gao et al. 2004). Micropropagation of shoot development on the MS medium, supplemented with 1-naphthaleneacetic (0.1 mg/l) and thidiazuron (0.1 mg/l) on Frangula alnus, was attained, and the production of secondary metabolite, anthraquinone, was maximum in the shoots than in the plant grown under normal condition (Namdeo 2007).

7.3.3 Secondary Metabolite Improvement by Addition of Precursors

The treatment of plant cells or tissue/organ with factors like biotic and/or abiotic has an expedient approach to enhance secondary metabolite fabrication grown under media culture (Karuppusamy 2009). The utmost commonly used precursors in prior studies were yeast extract, fungus, polysaccharides, methyl jasmonate, and chitosan. One of the most recognized elicitor methyl jasmonate is an established indicator compound and is the most effectual elicitor for Taxol fabrication in T. chinensis Roxb (Wink et al. 2008). Gonsenoside, a secondary metabolite found in P. ginseng, can be illicitly produced in the supplemented media in Meyer cell/organ culture (Yagi et al. 1983; Xu et al. 2008; Yamanaka et al. 1996).

Biosynthesis of hyperforin and adhyperforin by shoot culture process of H. perforatum when treated with amino acids was reported (Kim et al. 2004). Upon supplementation of shoot cultures by amino acids, valine conformed to side chain of hyperforin and isoleucine conformed to side chain of adhyperforin, separately. Nourishing the shoot cultures with amino acid like isoleucine (2 mM) prompted three- to sevenfolds of elicitation in the production of hyperforin (Kim et al. 2004). It was reported that, when amino acids (leucine) were treated in callus and cell suspension cultures of Centella asiatica, the triterpene production was increased. The method was found to be quite impressive for the elicitation of asiaticoside. In the callus culture, multifarious increase of asiaticoside was observed by this approach (Karppinen et al. 2007).

7.3.4 In Vitro Elicitation Technique

In vitro treatment of cells or tissue/organ by microbial, physical, or chemical elements which causes morphological and physiological changes is called “elicitation,” and the compounds are so-called elicitors. An elicitation is a method of tempting or enhancing the fabrication of secondary metabolites by cells or tissue/organ culture to make sure of their existence, perseverance, and effectiveness (Karuppusamy 2009; Kiong et al. 2005). In a study, abiotic elicitor was applied in the hairy roots of P. ginseng to improve growth and to elicit ginseng saponin biosynthesis. However in the study, elicitor treatments were performed to inhibit the development of the root hairs, but at the same time it was enhancing the content of ginseng saponin biosynthesis (Jeong and Park 2006). Elicitor treatment of benzo (1,2,3)-thiadiazole-7-carbothionic acid S-methyl ester and autoclaved lysate of cell suspension of E. sakazaki was done for the fabrication of secondary metabolites in callus culture, cell suspension culture, and hairy roots of Ammi majus. The study showed noteworthy outcomes (Staniszewska et al. 2003). The investigation based on GC and GC-MS estimation of methanolic and chloroform excerpts exhibited greater accretion of umbelliferone in the treated (elicited) tissues (Staniszewska et al. 2003). In a study on Rubia akane cell culture, chitosan (polysaccharide) was used as a biotic elicitor. The results were prompting the multifarious upsurge of anthraquinone fabrication (Jin et al. 1999).

7.3.5 Enhancement of Secondary Metabolites by Cultures of Hairy Root

Secondary metabolite synthesis in plant roots, based on inoculation by Agrobacterium rhizogenes with hairy root system, has become common in the past few years (Palazon et al. 1997; Karuppusamy 2009). However, in the absence of lateral root branching, physical factor like geotropism and factor like genetic stability could affect the growth of the root hair, ultimately affecting the production of secondary metabolite by hairy root culture technique. Hairy roots ascending for the formation of secondary metabolites by the treatment of plant material by A. rhizogenes are analogous to those normally produced by parent roots of whole plant, with parallel or greater yields (Sevón and Oksman-Caldentey 2002). The unperturbed genetic stability and sudden advancement in normal media that are deficient in hormones mark them particularly appropriate for biochemical analysis, which was not easy to undertake in root hair cultures of plant. The hairy roots of the plant are firstly sterilized and then interact with the parts of the plant by infecting it with A. rhizogenes. For the period of the interaction course, A. rhizogenes transmits the portion of DNA (T-DNA) situated in the root-persuading plasmid to plant cells, and the confined genes in the region are expressed in the identical manner as the normal endogenous genes of the plant cells. Some strain of A. rhizogenes (like A4) possess T-DNA divided into two segments (i.e., TL-DNA and TR-DNA). Thus, both are assimilated independently into the plant’s genome (Jouanin 1984).

7.3.6 Production of Secondary Metabolite by Genetic Transformation in Hairy Root Culture

Genetically transformed roots deliver a favorable substitute for biotechnological utilization of the plant cells (Pandey et al. 2014). A. rhizogenes intervened with the transformation of plant’s genome, which could be utilized in the way similar to well-established technique, engaging A. tumefaciens. The transformation of A. rhizogenes enables the growth of plantlets that have been renewed and also to yield transgenic cultures of hairy root of the plant (Karuppusamy 2009). The exclusion of the limiting sequences, not any of the supplementary T-DNA sequences are obligatory for the transmission. The leftover T-DNA could be switched by the external DNA (sequences are firmly hereditary in a Mendelian fashion) and inserted into the cells by which the regeneration of the whole plants can be achieved (Zambryski et al. 1989). Transformations by A. rhizogenes possess advantage of being capable to relocate any external gene of prominence, situated in transformed clone of binary vector of hairy root. In a study, the gene of interest with respect to enhancement of secondary metabolism was introduced into hairy roots. In the process 6-hydroxylase gene of Hyoscyamus muticus was incorporated in hyoscyamine-rich Atropa belladonna by the help of A. rhizogenes. An amplified quantity of enzymatic activity with five times more concentration of scopolamine was observed in engineered roots (Hashimoto et al. 1993).

7.3.7 In Vitro Secondary Metabolite Production by Endophytes

There are three origins of supports on the formation of secondary metabolites produced by plants. There is disagreement that plants and endophytic microorganism are coevolved with similar pathways to form these naturally occurring products. One more assumption states that primeval horizontal gene transmission is attained among plants and endophytic microorganism. The last suggestion is that moreover plants or endophytic fungus yield particular secondary metabolites, thus relocating them to the other symbiotic organism (Karuppusamy 2009; Jennewein et al. 2001). Studies based on radiolabeling of biosynthetic pathways by means of precursor-like amino acids show that fungal endophyte and plants have analogous but different metabolic paths for the fabrication of secondary metabolites (Zhang et al. 2009). It is still under investigation that whether the phytochemicals produced by the plants are naturally produced or it is the result of a mutualistic association of beneficial organisms with the plant. However studies reveal that the blend of influencing factors of plants and fungal endophyte upsurges the secondary metabolite accumulation in both the organisms (Li et al. 2009; Engels et al. 2008). However, the symbiotic relationship among plants and fungal endophytes and the effects on each other in the course of production of substantial bio-active compounds (therapeutically significant) could be processed. This could deliver the background for upcoming natural product fabricated by the process of genetic engineering and metabolic engineering (Komaraiah et al. 2003).

7.3.8 Secondary Metabolites Scaling-Up by the Use of Bioreactors

In this technique bioreactors are used for large-scale production of secondary metabolites. This can be achieved thru scaling-up, by the use of bioreactors, for large-scale modification of plant cells. The process would lead to the formation of exclusive bio-active phytochemicals in a vigorous process. During the process, the plant cells in liquescent suspension provide a distinctive combination of physicochemical environs that is essential for bioreactor’s large-scale progression (Ruffoni et al. 2010; Gupta et al. 2014). The fabrication of secondary metabolites using bioreactor from cell culture of Sandalwood and Periwinkle was done by Valluri (2009). In the study, the activity of phenylalanine ammonia lyase was inhibited by the use of trans-cinnamic acid; as a result substantial upsurge in the formation of alkaloid from the cell culture of periwinkle was observed. When cells were exposed to mannitol-induced osmotic stress, it yields noticeable enhancement in the production of total alkaloid. Biotic and abiotic stresses induce additive stimulation in alkaloid accumulation. However, no secondary metabolites (essential oils) are identified, in the form of phenolics from sandalwood cell cultures manufactured in the bioreactor (Valluri 2009).

7.3.9 Secondary Metabolite Immobilization and Accumulation

Advancements in immobilization techniques and scaling-up methodologies provide significant upsurge in numerous plant cell/tissue culture applications, for the formation of bio-active compounds with prominent and additional importance. Compounds derived from plants with anticancer, chemotherapeutic, or antioxidative properties use Taxol and rosmarinic acid in place of therapeutic agent. Cell cultures of Plumbago rosea were immobilized in calcium alginate. It was then cultured in MS media containing 10 mM calcium chloride for the formation of plumbagin, an essential therapeutic compound. Investigations were performed to elucidate the influence of immobilization on improved deposition of secondary metabolite (plumbagin). Calcium alginate immobilization improved the formation of plumbagin by one- to threefold increase, as compared to control (Vanisree and Tsay 2004).

7.3.10 Secondary Metabolite Production by Metabolic Engineering

Metabolic engineering encompasses the objective and focuses modification of metabolic pathways occurs in an organism. It would deliver improved knowledge and usage of various cellular pathways for supramolecular assembly, transduction of energy, and alteration of chemical (Lessard 1996). This method implements on plants which will allow endogenous pathways (biochemical pathways) to be influenced and could result in the development of transgenic crops. Thus in the process, the synthesis of natural products by the plants is altered to deliver valuable biomolecules of therapeutic significance (Kinney 1998). As in numerous studies, fabrication of secondary metabolites is excessively low to be used commercially; therefore metabolic engineering can offer several approaches to:
  • Better output, like by increasing the number of cells employed for producing secondary metabolites.

  • Overexpression of genes could increase the carbon flux by making use of biosynthetic pathway.

  • Categorize for rate regulation of enzyme or hindering feedback and competitive inhibition mechanism.

  • Reduction in catabolism.

A number of genes coding biosynthetic pathways of alkaloids such as nicotine, berberine, and scopolamine were engineered and executed. Cloned gene expression of two enzymes, viz., putrescine N-methyltransferase and (S)-scoulerine 9-O-methyltransferase, in A. belladonna and N. sylvestris (transgenic plants), respectively, in cell culture of C. japonica and E. californica, respectively, was performed. The results reveal that putrescine N-methyltransferase was overexpressed and amplified the content of nicotine in N. sylvestris (Sato et al. 2001). Metabolic engineering by yeast is another technique for the fabrication of valued secondary metabolites. Thus by exploiting yeast, the cloning of genes from different plant species and microorganisms can be done easily. It can be done for the production of the following:
  • Flavonoid production using yeast (Yan et al. 2005)

  • Terpenoid production using yeast:
    • Monoterpenoids production using yeast (Oswald et al. 2007)

    • Sesquiterpenes production using yeast (Ro et al. 2007)

    • Carotenoids production using yeast (Gunel et al. 2006)

  • Alkaloid production (plant-origin) by using yeast (Geerlings et al. 2001)

7.4 Secondary Metabolites of Pharmacological Significance

Exploration in the arena of tissue culture (plant) technique has led to the formation of various phytochemicals of therapeutic significance, which are beneficial for human health. New-fangled developments in the production of therapeutic compounds by cell culture technique hassled to extensive assortment of medications such as phenolics, alkaloids, saponins, terpenoids, steroids, amino acids, flavonoids, etc. (Abdin and Kamaluddin 2006; Jordon and Wilson 1995). Efficacious efforts to yield some of these valued medications in comparatively bulky amounts by cell cultures are Taxol (paclitaxel) (Cragg et al. 1993; Fett-Neto et al. 1994; Suffness 1995), diosgenin (Tal et al. 1983; Zenk et al. 1978), L-3, 4-dihydroxyphenylalanine or L-DOPA (Daxenbichler et al. 1971; Brain and Lockwood 1976), capsaicin (Holden et al. 1988; Ravishankar et al. 2003; Sanatombi and Sharma 2007), camptothecin (Sakato and Misawa 1974; Thengane et al. 2003), morphine and codeine (Furuya et al. 1972; Yoshikawa and Furuya 1985), and berberine (Hara et al. 1991; Vanisree et al. 2004). Some of the structures of the secondary metabolites are given in Fig. 7.2.
../images/470709_1_En_7_Chapter/470709_1_En_7_Fig2_HTML.png
Fig. 7.2

Structure of secondary metabolites of therapeutic importance

7.5 Secondary Metabolites Significant in Healthcare

Certain secondary metabolites possess explicit effectiveness in healthcare which is superfluous to conventional vitamin utilities, for instance, the importance of carotenoids such as lutein and zeaxanthin are required for muscular strength (Roberts et al. 2009; Bai et al. 2011). Presently, there is considerable attention paid in potentially long-standing nutritional assistance by amplified usage of wide range of plants derived secondary metabolites. The extraction process of secondary metabolite and its application are summarized in Fig. 7.3. Several in vitro and in vivo investigations like epidemiological study, minor animal trials, and nutritional interference trials have delivered indications that secondary metabolite consumptions cause cancer reduction, reduced level of cardiovascular diseases, several metabolic disorder, and several neuron disintegration syndromes like Alzheimer’s or Parkinson’s disease (Crozier et al. 2009; Miller and Snyder 2012). Despite the validity of all the outcomes of the investigations, the probable mechanism pathways for health-related benefits are still unexplained. Several previous investigations reveal evident worth of secondary metabolite intake, which were due to their antioxidant properties (Iqbal et al. 2014a, b; Tripathi et al. 2016). On the other hand, the correlation between antioxidant activities to the findings monitored in in vitro explorations on animal/human trials marks qualm on the antioxidant postulate (Rastogi et al. 2018). However, phytochemicals like phenolics; carotenoids; glucosinolates; vitamins B, C, and E; folates; isothiocyanates; glutathione; and lycopene have been reported to possess substantial antioxidant ability. Nevertheless, various investigations currently focus on other activities other than antioxidant properties, as there are several other types of metabolites which possess distinct property. Trials based on human involvement, genetically modified prototypes, and animal models possessing isogenic lines have been investigated, but there is still a shortage of well-organized investigations, precisely analyzing the acclaimed health benefits of secondary metabolites. The benefits and drawbacks of various bases of validation for the effects on health and action mechanism of secondary metabolites of plants have been extravagantly reviewed by Traka and Mithen (2011). While going through the literature, irrespective of the mechanistic action of secondary metabolite, it is ostensible that various investigators contemplate their views, indicating that several plant secondary metabolites actually do have noteworthy benefits associated to health.
../images/470709_1_En_7_Chapter/470709_1_En_7_Fig3_HTML.png
Fig. 7.3

Systematic representation of secondary metabolite production and its biological application

An additional barrier in outlining an appropriate dosage of a particular secondary metabolite in food is microbiota of the human, which interacts in the metabolic action and absorption of compounds. An equivalent quantity of secondary metabolite could affect differently, which may cause diverse levels of reaction in different individuals. This deviation in effect is associated to persons’ genetic character, age, fitness level, and medications. On the other hand, an auxiliary difficulty is that for several secondary metabolites to be taken into account its bioavailability. The particular secondary metabolite can consecutively influence the tissues with its various effects; further, it could be responsible for the metabolic transformation of the tissues as well. Therefore, it requires information of the absorption, metabolic action, position, and, eventually, defecation of respective bio-active compound, based on the trials on human/animal models to investigate these factors.

As we know, fruits and vegetables are the source of innumerable sets of secondary metabolites taken by our body. These phytochemicals are significant to understand how every compound is absorbed, and, therefore, its bioavailability can be elucidated. Although, most of the studies emphasize on bioavailability of plant-derived secondary metabolites in human/animal tissues. However the actual effect might be subsidiary, as it is intermediated by means of modifications by gut’s microbiota which may support to elucidate the inconsistency among the comparatively low grade of apparent bioavailability and its definite nutritional advantages (Duynhoven et al. 2011; Manach et al. 2009). Moreover, the existence of particular enterotypes is more persistently linked with nutrition than ethnicity or topography. The association of microbiota enterotype might affect both the individual’s possibility of chronic ailment and also have an impact on the way bio-active compounds are absorbed. It is probably that particular enterotypes will be affected by continuing specific dietary habit, but also short nutritive mediation of merely for a day could modify microbiome association (Wu et al. 2011). Though the multifarious interrelationship with microbiota are usually mutualistic, it could turn out to be pathological, for instance, in the situation of inflammatory bowel disease (Fava and Danese 2011). Minor population of bifidobacteria and greater occurrence of gastrointestinal pathogenic bacteria like E. coli, Campylobacter, Helicobacter, and Salmonella are frequently related to chronic immune diseases. Food can also affect the peril aspects, such as metabolic syndrome, which are generally related with fast food and junk dietaries, and could cause metabolic syndromes like obesity and diabetes (Fava et al. 2013).

Extensive effect of flavonoids, in human-involved investigations, on cardiac risk disease associated with high and low levels of flavonoid intakes over a period of 18 weeks revealed an upsurge in potentially valuable bacterial groups for the high flavonoid intake, for example, as in Bifidobacterium (Chong et al. 2013). Polyphenolics are another category of secondary metabolites. Polyphenols are mostly well-examined biomolecule, and they are permitted through metabolic action and are abdominally absorbed (McGhie and Walton 2007). Relating to the diet, polyphenols are mainly delivered by fruits, vegetables, grains, and beverages like tea, coffee, wine, and beer (Grosso et al. 2014). Anthocyanin is a class of phytosecondary metabolite. Its constancy of structure is determined by the type of sugar component associated. The anthocyanins are derived compounds like gallic acid, protocatechuic acid, syringic acid, and aglycones, which are revealed to be biotransformed by microflora (Forester and Waterhouse 2010). The bacterial-reliant metabolic action of anthocyanins can then, in turn, modify abdominal bacterial inhabitant like Lactobacillus and Bifidobacterium, recommending an optimistic association among bacterial condition and phytochemical intake (Hidalgo et al. 2012). As earlier reviewed, studies associated to human subjects have established the absorption of secondary metabolites derived from plant, but elucidating the consequence of the method and the metabolic outcome still faces methodological challenges. The approaches like using bioinformatical tools (next-generation sequencing or meta-genomics) and animal/human model studies would improve our knowledge of the secondary metabolite interaction with tissue and its metabolism. It would elucidate the pathways of metabolism of secondary metabolite and the development of future nutritional food with enhanced level of secondary metabolites which could be obtained naturally.

7.6 Conclusions and Future Prospects

Secondary metabolites produced by the plants support them to contest and stay alive in extreme environmental conditions. Various biotechnological methodologies are employed for fabrication and enhancement of secondary metabolites by genetic engineering process and plant tissue culture techniques. Genomic knowledge by metabolic engineering for fabrication of secondary metabolites derived from plants is presently well innovated. Thus, metabolic engineering and biotechnological exercises can be applied as a substitute for the production of naturally active, economically valuable, and pharmaceutically important secondary metabolite. Developments in bio-techniques, mainly the technique of plant cell cultures, could deliver new worth for therapeutically and economically bio-active compounds. The main benefit of the in vitro cell cultures comprises the fabrication of secondary metabolites, cultivated in controlled environmental conditions, thus enabling us to extract important and particular phytochemicals in elicited quantities. The practice of genetic engineering is another emerging tool which can regulate the pathways for the fabrication of therapeutically significant secondary metabolites. Knowledge of biosynthesis of desired phytochemicals obtained from plants and its cultures are still in its preliminary stages; therefore accordingly approaches are required to advance the information based on molecular and cellular level. The advancement in new-fangled methods of molecular biology to yield cultures by transgenic and to understand the effect of the expression and regulation of biosynthetic pathways is possibly to be a noteworthy step in the direction of making cell culture technique more relevant to produce commercially important secondary metabolites. These new techniques will contribute to spread and improve the sustained efficacy of higher plants as non-conventional sources of compounds, specifically therapeutic compounds. It is anticipated in this field that prolonged and escalated efforts will lead to contribute efficacious biotechnological fabrication of secondary metabolites. It is further to be explained the effect of particular secondary metabolite associated with health benefits, which could be useful for neutraceutical and pharmaceutical industries. This in turn could permit the elucidation of innovative bio-active compounds and support to fix objectives for the improvement of nutritionally efficient foodstuffs for health benefits.